Luminal A versus luminal B breast cancer: MammaTyper mRNA versus immunohistochemical subtyping with an emphasis on standardised Ki67 labelling‐based or mitotic activity index‐based proliferation assessment
Sign Up to like & getrecommendations! Published in 2019 at "Histopathology"
DOI: 10.1111/his.14048
Abstract: Proliferation assessment by the use of Ki67 is a crucial component in intrinsic subtyping of luminal breast cancers (BCs), but suffers from variability between laboratories, observers, and methods. MammaTyper is a quantitative molecular tool that… read more here.
Keywords: proliferation assessment; versus luminal; luminal breast; proliferation ... See more keywords